Skip to content
  • beauty
  • industrial

Buddleja axillaris leaf extract

CAS 608134-67-4

Concern score

Not assessed — no hazard data yet.

Buddleja axillaris leaf extract in plain language

What it is

Also known as Buddleja axillaris leaf · Adenoplusia axillaris leaf · Adenoplusia ulugurensis leaf · Adenoplusia willdenowii leaf · Buddleja comorensis leaf

What it does

Used in cosmetics as an antioxidant, a skin-conditioning agent and a bleaching agent. Buddleja Axillaris Leaf Extract is the extract of the leaves of Buddleja axillaris, Loganiaceae.

  • Antioxidant
  • Skin conditioning
  • Bleaching
  • Skin protecting
  • Humectant
  • Conditioner
Is it a concern?
We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.

Regulation

No restrictions found. Buddleja axillaris leaf extract appears in these published regulatory listings.

Recorded in these product areas

  • Found in consumer products
  • Industrial
  • USFDAlisted in openFDA substance2 entries
    • openFDA substance registry classifies this ingredient as concept.Source →
    • openFDA substance registry classifies this ingredient as structurallydiverse.Source →
  • EUCosIngActiveBuddleja Axillaris Leaf Extract is the extract of the leaves of Buddleja axillaris, Loganiaceae
    • Buddleja Axillaris Leaf Extract is the extract of the leaves of Buddleja axillaris, LoganiaceaeSource →
  • USEPAcommercial use observedEPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Antioxidant, Humectant, Softener and conditioner.
    • EPA CPDat observed this chemical in 0 composition records across product categories including unclassified products. EPA CPDat classifies this chemical for functional uses including Antioxidant, Humectant, Softener and conditioner.Source →

Expert safety opinions

No expert opinion on file for Buddleja axillaris leaf extract. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.

  • SCCS

    EU Scientific Committee on Consumer Safety

    No SCCS opinion on file.

  • CIR

    Cosmetic Ingredient Review (US expert panel)

    No CIR safety assessment on file.

Evidence & sources

No graded research studies for Buddleja axillaris leaf extract yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

5 data sources

Where this comes from

  • CosIng

    regulatory · updated 2026-09-23

    Open →
  • EPA Chemical and Products Database

    exposure · updated 2019-12-20

    Open →
  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →
  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →
  • openFDA Substance

    registry · updated 2026-05-24

    Open →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Where it has been recorded

How often EPA CPDat has listed Buddleja axillaris leaf extract in a product composition. These are source records, not Greenveil catalog products.

Named organisations

1

Typical roles

AntioxidantSkin conditioningBleachingSkin protectingHumectantConditioner
See products using Buddleja axillaris leaf extract →